Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,526 | -44,904 | -164,076 | -127,997 | -92,475 |
| Depreciation Amortization | -4,926 | -1,512 | 1,026 | -2,790 | -1,553 |
| Accounts payable and accrued liabilities | 14,121 | -934 | -625 | 4,168 | 2,886 |
| Other Working Capital | -32,561 | -68 | -37,016 | -13,892 | -3,727 |
| Other Operating Activity | -11,176 | 3,120 | -7,820 | -3,041 | 78 |
| Operating Cash Flow | $-120,068 | $-44,298 | $-208,511 | $-143,552 | $-94,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -749,787 | N/A | -329 | -719 | 94,040 |
| PPE Investments | -112 | -18 | -171 | -153 | -39 |
| Net Acquisitions | N/A | N/A | -697 | N/A | N/A |
| Purchase Of Investment | N/A | -452,253 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 101,482 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -697 | -697 |
| Investing Cash Flow | $-749,899 | $-350,789 | $-1,197 | $-1,569 | $93,304 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 895,357 | 529,574 | 181,716 | 143,045 | 218 |
| Other Financing Activity | -1,239 | -25 | -1,150 | -1,150 | 0 |
| Financing Cash Flow | $894,118 | $529,549 | $180,566 | $141,895 | $218 |
| Exchange Rate Effect | N/A | N/A | 6 | 6 | 5 |
| Beginning Cash Position | 15,116 | 15,116 | 44,252 | 44,252 | 44,252 |
| End Cash Position | 39,267 | 149,578 | 15,116 | 41,032 | 42,988 |
| Net Cash Flow | $24,151 | $134,462 | $-29,136 | $-3,220 | $-1,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,068 | -44,298 | -208,511 | -143,552 | -94,791 |
| Capital Expenditure | -112 | -18 | -171 | -153 | -39 |
| Free Cash Flow | -120,180 | -44,316 | -208,682 | -143,705 | -94,830 |